Skip to main content
  • Guideline Summary
  • NGC:009595
  • 2011 Aug 15

Position statement on screening mammography.

American Society of Breast Surgeons. Position statement on screening mammography. Columbia (MD): American Society of Breast Surgeons; 2011 Aug 15. 1 p. [4 references]

View the original guideline documentation External Web Site Policy

This is the current release of the guideline.

Major Recommendations

The American Society of Breast Surgeons supports annual screening mammography for women age 40 and older. Numerous studies have demonstrated that screening mammography leads to improved survival due to earlier detection of breast cancer, including in women age 40-49. While mammography is less sensitive in younger women and in women with dense breast tissue, the use of digital mammography improves the rate of detection in these women. Some breast cancers will be missed due to breast density or other factors, and some patients will undergo additional imaging or even biopsy for lesions that are subsequently found not to be malignant. However despite the limitations, screening mammography remains the most cost-effective, practical, and accurate screening tool available for the early detection of breast cancer at this time. Patients with breast cancers detected in an earlier stage are more likely to be candidates for breast-conserving surgery, less likely to require chemotherapy, and will have an improved survival compared to women who have their cancers diagnosed at a later stage. Women should be aware of their risk factors and should discuss their concerns regarding screening mammography with their physician.

Clinical Algorithm(s)

None provided

Disease/Condition(s)

Breast cancer

Guideline Category

Screening

Clinical Specialty

Family Practice

Obstetrics and Gynecology

Oncology

Radiology

Surgery

Intended Users

Advanced Practice Nurses

Physician Assistants

Physicians

Guideline Objective(s)

To provide recommendations concerning annual screening mammography for women age 40 and older

Target Population

Women age 40 and older

Interventions and Practices Considered

Annual screening mammography for women age 40 and older

Major Outcomes Considered

  • Earlier detection of breast cancer
  • Improved survival rates

Methods Used to Collect/Select the Evidence

Searches of Electronic Databases

Description of Methods Used to Collect/Select the Evidence

  • A medical librarian conducted a database search (MEDLINE/PubMed - US National Library of Medicine)
  • The time frame of the literature search(es) was between June and July of 2011.
  • There were no specific inclusion/exclusion criteria. The librarian researched mammography screening articles both from published literature as well as other medical specialty society position statements.
  • Specific search terms used included "mammogram," "screening," and "guidelines."

Number of Source Documents

Not stated

Methods Used to Assess the Quality and Strength of the Evidence

Expert Consensus

Rating Scheme for the Strength of the Evidence

Not applicable

Methods Used to Analyze the Evidence

Review

Description of the Methods Used to Analyze the Evidence

Internal review/consensus

Methods Used to Formulate the Recommendations

Expert Consensus

Description of Methods Used to Formulate the Recommendations

Internal review/consensus

Rating Scheme for the Strength of the Recommendations

Not applicable

Cost Analysis

A formal cost analysis was not performed and published analyses were not reviewed.

Method of Guideline Validation

Internal Peer Review

Description of Method of Guideline Validation

This position statement was approved on August 15, 2011 by the American Society of Breast Surgeons Board of Directors.

Type of Evidence Supporting the Recommendations

The type of evidence supporting the recommendations is not specifically stated.

Potential Benefits

Patients with breast cancers detected in an earlier stage are more likely to be candidates for breast-conserving surgery, less likely to require chemotherapy, and will have an improved survival compared to women who have their cancers diagnosed at a later stage.

Potential Harms

Mammography is less sensitive in younger women and in women with dense breast tissue.

Description of Implementation Strategy

An implementation strategy was not provided.

Implementation Tools

Resources

For information about availability, see the Availability of Companion Documents and Patient Resources fields below.

IOM Care Need

Staying Healthy

IOM Domain

Effectiveness

Bibliographic Source(s)

American Society of Breast Surgeons. Position statement on screening mammography. Columbia (MD): American Society of Breast Surgeons; 2011 Aug 15. 1 p. [4 references]

Adaptation

Not applicable: The guideline was not adapted from another source.

Date Released

2011 Aug 15

Guideline Developer(s)

American Society of Breast Surgeons - Professional Association

Source(s) of Funding

The American Society of Breast Surgeons

Guideline Committee

Board of Directors, The American Society of Breast Surgeons

Composition of Group That Authored the Guideline

Not stated

Financial Disclosures/Conflicts of Interest

Not stated

Guideline Status

This is the current release of the guideline.

Guideline Availability

Electronic copies: Available in Portable Document Format (PDF) from the American Society of Breast Surgeons Web site External Web Site Policy.

Availability of Companion Documents

The following is available:

Patient Resources

None available

NGC Status

This NGC summary was completed by ECRI Institute on April 15, 2013. The information was verified by the guideline developer on May 13, 2013.

Copyright Statement

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

NGC Disclaimer

The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx.

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.